Grover S - Search Results

1

Vitamin D intake is associated with decreased risk of immune checkpoint inhibitor-induced colitis.

Grover S, Dougan M, Tyan K, Giobbie-Hurder A, Blum SM, Ishizuka J, Qazi T, Elias R, Vora KB, Ruan AB, Martin-Doyle W, Manos M, Eastman L, Davis M, Gargano M, Haq R, Buchbinder EI, Sullivan RJ, Ott PA, Hodi FS, Rahma OE. Grover S, et al. Cancer. 2020 Aug 15;126(16):3758-3767. doi: 10.1002/cncr.32966. Epub 2020 Jun 22. Cancer. 2020. PMID: 32567084 Free PMC article.

2

Gastrointestinal and Hepatic Toxicities of Checkpoint Inhibitors: Algorithms for Management.

Grover S, Rahma OE, Hashemi N, Lim RM. Grover S, et al. Am Soc Clin Oncol Educ Book. 2018 May 23;38:13-19. doi: 10.1200/EDBK_100013. Am Soc Clin Oncol Educ Book. 2018. PMID: 30231401 Free article. Review.

3

Lymphocytic colitis-like pattern of mucosal injury and the challenges in diagnosing cancer immunotherapy-related toxicity.

Grover S, Srivastava A. Grover S, et al. Cancer. 2019 Jun 1;125(11):1768-1770. doi: 10.1002/cncr.32005. Epub 2019 Mar 20. Cancer. 2019. PMID: 30892689 Free article. No abstract available.

4

Morphological spectrum of immune check-point inhibitor therapy-associated gastritis.

Johncilla M, Grover S, Zhang X, Jain D, Srivastava A. Johncilla M, et al. Among authors: grover s. Histopathology. 2020 Mar;76(4):531-539. doi: 10.1111/his.14029. Epub 2020 Feb 18. Histopathology. 2020. PMID: 31692018

5

Safety of Immune Checkpoint Inhibitors in Patients With Pre-Existing Inflammatory Bowel Disease and Microscopic Colitis.

Grover S, Ruan AB, Srivoleti P, Giobbie-Hurder A, Braschi-Amirfarzan M, Srivastava A, Buchbinder EI, Ott PA, Kehl KL, Awad MM, Hodi FS, Rahma OE. Grover S, et al. JCO Oncol Pract. 2020 Sep;16(9):e933-e942. doi: 10.1200/JOP.19.00672. Epub 2020 May 13. JCO Oncol Pract. 2020. PMID: 32401685

6

Gastroparesis Following Immune Checkpoint Inhibitor Therapy: A Case Series.

Atieh J, Sack J, Thomas R, Rahma OE, Camilleri M, Grover S. Atieh J, et al. Among authors: grover s. Dig Dis Sci. 2021 Jun;66(6):1974-1980. doi: 10.1007/s10620-020-06440-x. Epub 2020 Aug 7. Dig Dis Sci. 2021. PMID: 32594464 Free PMC article.

7

Correction to: Gastroparesis Following Immune Checkpoint Inhibitor Therapy: A Case Series.

Atieh J, Sack J, Thomas R, Rahma OE, Camilleri M, Grover S. Atieh J, et al. Among authors: grover s. Dig Dis Sci. 2021 Aug;66(8):2843-2844. doi: 10.1007/s10620-020-06515-9. Dig Dis Sci. 2021. PMID: 32767043 No abstract available.

8

Management of immunotherapy colitis: Special considerations in the COVID-19 era.

Grover S, Bond SA, Mansour MK, Friedman S. Grover S, et al. Cancer. 2020 Nov 1;126(21):4630-4633. doi: 10.1002/cncr.33125. Epub 2020 Aug 14. Cancer. 2020. PMID: 32797685 Free PMC article.

9

Novel platform leveraging electronic medical record (EMR) to triage patients admitted with high-grade immune-related adverse events (irAEs) to the immune-toxicity (ITOX) service.

Abu-Shawer O, Singh P, Yenulevich E, Brito A, Ni J, Abdulnour RE, Grover S, Manos M, Bowling P, LeBoeuf NR, Ott P, Stephen Hodi F, Jacobson J, Rahma O. Abu-Shawer O, et al. Among authors: grover s. J Immunother Cancer. 2020 Aug;8(2):e000992. doi: 10.1136/jitc-2020-000992. J Immunother Cancer. 2020. PMID: 32817360 Free PMC article.

10

Outcomes after resumption of immune checkpoint inhibitor therapy after high-grade immune-mediated hepatitis.

Li M, Sack JS, Rahma OE, Hodi FS, Zucker SD, Grover S. Li M, et al. Among authors: grover s. Cancer. 2020 Dec 1;126(23):5088-5097. doi: 10.1002/cncr.33165. Epub 2020 Sep 5. Cancer. 2020. PMID: 32888341 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,435 results

Search Page

Filters